|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 28, 2016 ) Publisher's, 'Type 2 Diabetes - Pipeline Review, H1 2016', provides an overview of the Type 2 Diabetes pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Type 2 Diabetes and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Type 2 Diabetes
- The report reviews pipeline therapeutics for Type 2 Diabetes by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Type 2 Diabetes therapeutics and enlists all their major and minor projects
- The report assesses Type 2 Diabetes therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Type 2 Diabetes
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001242040/sample
Table of Content: An Overview
Table of Contents 2
Introduction 12
Type 2 Diabetes Overview 13
Therapeutics Development 14
Type 2 Diabetes - Therapeutics under Development by Companies 16
Type 2 Diabetes - Therapeutics under Investigation by Universities/Institutes 36
Type 2 Diabetes - Pipeline Products Glance 40
Type 2 Diabetes - Products under Development by Companies 44
Type 2 Diabetes - Products under Investigation by Universities/Institutes 79
Type 2 Diabetes - Companies Involved in Therapeutics Development 85
Type 2 Diabetes - Therapeutics Assessment 306
Drug Profiles 341
Type 2 Diabetes - Recent Pipeline Updates 1064
Type 2 Diabetes - Dormant Projects 1202
Type 2 Diabetes - Discontinued Products 1244
Type 2 Diabetes - Product Development Milestones 1263
Appendix 1268
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001242040/discount
List of Tables
Number of Products under Development for Type 2 Diabetes, H1 2016 74
Number of Products under Development for Type 2 Diabetes - Comparative Analysis, H1 2016 75
Number of Products under Development by Companies, H1 2016 77
Number of Products under Development by Companies, H1 2016 (Contd..1) 78
Number of Products under Development by Companies, H1 2016 (Contd..2) 79
Number of Products under Development by Companies, H1 2016 (Contd..3) 80
Number of Products under Development by Companies, H1 2016 (Contd..4) 81
Number of Products under Development by Companies, H1 2016 (Contd..5) 82
Number of Products under Development by Companies, H1 2016 (Contd..6) 83
Number of Products under Development by Companies, H1 2016 (Contd..7) 84
Number of Products under Development by Companies, H1 2016 (Contd..8) 85
Number of Products under Development by Companies, H1 2016 (Contd..9) 86
Number of Products under Development by Companies, H1 2016 (Contd..10) 87
Number of Products under Development by Companies, H1 2016 (Contd..11) 88
Number of Products under Development by Companies, H1 2016 (Contd..12) 89
Number of Products under Development by Companies, H1 2016 (Contd..13) 90
Number of Products under Development by Companies, H1 2016 (Contd..14) 91
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001242040/buy/2500
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
